Hypothesis: Potential Utility of Serum and Urine Uromodulin Measurement in Kidney Transplant Recipients?

Por Bostom, Andrew G., Steubl, Dominik, Friedman, Allon N.
Publicado no Transplant Direct (2017)

Effect of Niacin on FGF23 Concentration in Chronic Kidney Disease

Por Rao, Madhumathi, Steffes, Michael, Bostom, Andrew, Ix, Joachim H.
Publicado em 2014

More than skin deep? Potential nicotinamide treatment applications in chronic kidney transplant recipients

Por Bostom, Andrew G, Merhi, Basma, Walker, Joanna, Robinson-Bostom, Leslie
Publicado no World J Transplant (2016)

Hypophosphatemic Effect of Niacin in Patients without Renal Failure: A Randomized Trial

Por Maccubbin, Darbie, Tipping, Diane, Kuznetsova, Olga, Hanlon, William A., Bostom, Andrew G.
Publicado em 2010

Inadequacy of Cardiovascular Risk Factor Management in Chronic Kidney Transplantation -- Evidence from the FAVORIT Study

Por Carpenter, Myra A., Weir, Matthew R., Adey, Deborah B., House, Andrew A., Bostom, Andrew G., Kusek, John W.
Publicado no Clin Transplant (2012)

Safety Events in Kidney Transplant Recipients: Results from the Folic Acid for Vascular Outcome Reduction in Transplant (FAVORIT) Trial

Por Weir, Matthew R., Gravens-Muller, Lisa, Costa, Nadiesda, Ivanova, Anastasia, Manitpisitkul, Wana, Bostom, Andrew G., Diamantidis, Clarissa J.
Publicado no Transplantation (2015)

The Effect of Extended Release Niacin on Markers of Mineral Metabolism in CKD

Por Malhotra, Rakesh, Katz, Ronit, Hoofnagle, Andrew, Bostom, Andrew, Rifkin, Dena E., Mcbride, Ruth, Probstfield, Jeffrey, Block, Geoffrey, Ix, Joachim H.
Publicado no Clin J Am Soc Nephrol (2018)

Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduct...

Por Dad, Taimur, Tighiouart, Hocine, Joseph, Alin, Bostom, Andrew, Carpenter, Myra, Hunsicker, Lawrence, Kusek, John W., Pfeffer, Marc, Levey, Andrew S., Weiner, Daniel E.
Publicado no Am J Kidney Dis (2016)

Kidney Function and Risk of Cardiovascular Disease and Mortality in Kidney Transplant Recipients: the FAVORIT Trial

Por Weiner, Daniel E, Carpenter, Myra A, Levey, Andrew S, Ivanova, Anastasia, Cole, Edward H, Hunsicker, Lawrence, Kasiske, Bertram L, Kim, S Joseph, Kusek, John W, Bostom, Andrew G
Publicado em 2012

Baseline Characteristics of Participants in the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial

Por Bostom, Andrew G., Carpenter, Myra A., Hunsicker, Lawrence, Jacques, Paul F., Kusek, John W., Levey, Andrew S., McKenney, Joyce L., Mercier, Renee Y., Pfeffer, Marc A., Selhub, Jacob
Publicado em 2008

BP, Cardiovascular Disease, and Death in the Folic Acid for Vascular Outcome Reduction in Transplantation Trial

Por Carpenter, Myra A., John, Alin, Weir, Matthew R., Smith, Stephen R., Hunsicker, Lawrence, Kasiske, Bertram L., Kusek, John W., Bostom, Andrew, Ivanova, Anastasia, Levey, Andrew S., Solomon, Scott, Pesavento, Todd, Weiner, Daniel E.
Publicado em 2014

Adiposity Patterns and the Risk for ESRD in Postmenopausal Women

Por Franceschini, Nora, Gouskova, Natalia A., Reiner, Alex P., Bostom, Andrew, Howard, Barbara V., Pettinger, Mary, Umans, Jason G., Brookhart, M. Alan, Winkelmayer, Wolfgang C., Eaton, Charles B., Heiss, Gerardo, Fine, Jason P.
Publicado no Clin J Am Soc Nephrol (2015)

B-type natriuretic peptide and cardiac troponin I are associated with adverse outcomes in stable kidney transplant recipients

Por Jarolim, Petr, Claggett, Brian L., Conrad, Michael J., Carpenter, Myra A., Ivanova, Anastasia, Bostom, Andrew G., Kusek, John W., Hunsicker, Lawrence G., Jacques, Paul F., Gravens-Mueller, Lisa, Finn, Peter, Solomon, Scott D., Weiner, Daniel E., Levey, Andrew S., Pfeffer, Marc A.
Publicado no Transplantation (2017)

Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort

Por Merhi, Basma, Shireman, Theresa, Carpenter, Myra A., Kusek, John W., Jacques, Paul, Pfeffer, Marc, Rao, Madhumathi, Foster, Meredith C., Kim, S. Joseph, Pesavento, Todd E., Smith, Stephen R., Kew, Clifton E., House, Andrew A., Gohh, Reginald, Weiner, Daniel E., Levey, Andrew S., Ix, Joachim H., Bostom, Andrew
Publicado no Am J Kidney Dis (2017)

Homocysteine-Lowering and Cardiovascular Disease Outcomes in Kidney Transplant Recipients: Primary Results from the Folic Acid for Vascular Outcome Reduction in Transplantation (FA...

Por Bostom, Andrew G., Carpenter, Myra A., Kusek, John W., Levey, Andrew S., Hunsicker, Lawrence, Pfeffer, Marc A., Selhub, Jacob, Jacques, Paul F., Cole, Edward, Gravens-Mueller, Lisa, House, Andrew A., Kew, Clifton, McKenney, Joyce L., Pacheco-Silva, Alvaro, Pesavento, Todd, Pirsch, John, Smith, Stephen, Solomon, Scott, Weir, Matthew
Publicado no Circulation (2011)